These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11118161)

  • 61. Perspectives on Identifying and Treating Familial Hypercholesterolemia in Childhood.
    ; de Ferranti SD; Kazi DS; ; Bibbins-Domingo K; Daniels S; Howaniec B; Khera AV; Newman TB; Vernacchio L
    Clin Chem; 2021 Oct; 67(10):1312-1317. PubMed ID: 34491300
    [No Abstract]   [Full Text] [Related]  

  • 62. Improving the detection of familial hypercholesterolaemia.
    Lan NSR; Martin AC; Brett T; Watts GF; Bell DA
    Pathology; 2019 Feb; 51(2):213-221. PubMed ID: 30579649
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Genetic Diagnosis in Familial Hypercholesterolaemia - no].
    Klose G
    Dtsch Med Wochenschr; 2017 May; 142(9):689-690. PubMed ID: 28454204
    [No Abstract]   [Full Text] [Related]  

  • 64. The role of genetic testing in dyslipidaemia.
    Berberich AJ; Hegele RA
    Pathology; 2019 Feb; 51(2):184-192. PubMed ID: 30558903
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Postmortem diagnosis of familial hypercholesterolaemia.
    Leadbeatter S; Stansbie D
    Br Med J (Clin Res Ed); 1984 Dec; 289(6459):1656. PubMed ID: 6439363
    [No Abstract]   [Full Text] [Related]  

  • 66. Familial Hypercholesterolemia: A Reportable Disorder.
    Kullo IJ
    Circulation; 2020 Nov; 142(21):1999-2001. PubMed ID: 33226870
    [No Abstract]   [Full Text] [Related]  

  • 67. Cascade screening for familial hypercholesterolaemia: implications of a pilot study for national screening programmes.
    Marks D; Thorogood M; Neil SM; Humphries SE; Neil HA
    J Med Screen; 2006; 13(3):156-9. PubMed ID: 17007658
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Screening in children for familial hypercholesterolaemia: start now.
    Groselj U; Wiegman A; Gidding SS
    Eur Heart J; 2022 Sep; 43(34):3209-3212. PubMed ID: 35511818
    [No Abstract]   [Full Text] [Related]  

  • 69. Further response to 'Decision to reject screening for familial hypercholesterolaemia is flawed' by Wald and Martin.
    Wald DS; Martin AC
    Arch Dis Child; 2022 Jan; 107(1):102-103. PubMed ID: 34656980
    [No Abstract]   [Full Text] [Related]  

  • 70. Familial hypercholesterolaemia and cascade testing in general practice: Lessons from COVID-19.
    Garrahy E; Heal C; Hespe CM; Radford J; Watts GF; Brett T
    Aust J Gen Pract; 2020 Dec; 49(12):859-860. PubMed ID: 33254219
    [No Abstract]   [Full Text] [Related]  

  • 71. DNA sequencing in familial hypercholesterolaemia: the next generation.
    Lazarte J; Hegele RA
    Eur J Prev Cardiol; 2021 Jul; 28(8):873-874. PubMed ID: 33623969
    [No Abstract]   [Full Text] [Related]  

  • 72. Responses to 'Decision to reject screening for familial hypercholesterolaemia is flawed' by Wald and Martin.
    Marshall J; Shortland Obe G; Hillier S; Brownsword R; Steele B
    Arch Dis Child; 2022 Jan; 107(1):102. PubMed ID: 34289993
    [No Abstract]   [Full Text] [Related]  

  • 73. An initiative to extend testing for familial hypercholesterolaemia across the U.K.
    Nicholls M
    Eur Heart J; 2015 Oct; 36(39):2627-8. PubMed ID: 26756048
    [No Abstract]   [Full Text] [Related]  

  • 74. Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation.
    Watts GF; Gidding S; Wierzbicki AS; Toth PP; Alonso R; Brown WV; Bruckert E; Defesche J; Lin KK; Livingston M; Mata P; Parhofer KG; Raal FJ; Santos RD; Sijbrands EJ; Simpson WG; Sullivan DR; Susekov AV; Tomlinson B; Wiegman A; Yamashita S; Kastelein JJ;
    Eur J Prev Cardiol; 2015 Jul; 22(7):849-54. PubMed ID: 24776375
    [TBL] [Abstract][Full Text] [Related]  

  • 75. DNA diagnosis of familial hypercholesterolemia.
    Schuster H
    Eur J Med Res; 1998 Feb; 3(1-2):42-4. PubMed ID: 9512966
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Large heterogeneity of mutations in the gene encoding the low-density lipoprotein receptor in subjects with familial hypercholesterolaemia.
    Muller PY; Miserez AR
    Atheroscler Suppl; 2004 Dec; 5(5):1-5. PubMed ID: 15556092
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cascade genetic screening for familial hypercholesterolemia.
    Leren TP
    Clin Genet; 2004 Dec; 66(6):483-7. PubMed ID: 15521974
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The LDLR variant T705I does not cause the typical phenotype of familial hypercholesterolaemia.
    Graham CA; Wright WT; McIlhatton BP; Young IS; Nicholls DP
    Atherosclerosis; 2006 Sep; 188(1):218-9. PubMed ID: 16735037
    [No Abstract]   [Full Text] [Related]  

  • 79. Molecular epidemiology of familial hypercholesterolaemia.
    Defesche JC; Kastelein JJ
    Lancet; 1998 Nov; 352(9141):1643-4. PubMed ID: 9853432
    [No Abstract]   [Full Text] [Related]  

  • 80. Familial hypercholesterolemia--epidemiology, diagnosis, and screening.
    Singh S; Bittner V
    Curr Atheroscler Rep; 2015; 17(2):482. PubMed ID: 25612857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.